Medicare negotiated the price of 10 popular medications to save enrollees money. Even more medications are scheduled for ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
MedPage Today on MSN
What to know about Medicare's hemp-derived product program
Providers will pay for the medications, which are only available to certain enrollees ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new program, called the Substance Access Beneficiary Engagement Incentive, is ...
• The agency also extended the deadline for drugmakers to enter participation agreements to July 17, from June 30. • CMS ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The Trump administration decided to put the pilot on hold until at least 2027.
The Centers for Medicare & Medicaid Services (CMS) will extend its temporary Medicare GLP-1 Bridge program for obesity drug coverage through the end of 2027, delaying the launch of a longer-term model ...
Industry stakeholders left a recent meeting with Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results